[CNTA] YoY Quarter Result on 31-Dec-2022 [#Q4]

Stock
[CNTA] Centessa Pharmaceuticals plc
Announcement Date
30-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 19.86%
YoY- 28.96%
Quarter Report
CNTA's Result
CNTA's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
Revenue 6,913 0 0 0 -
PBT -36,003 -43,837 -60,660 -3,286 122.10%
Tax 1,154 -664 114 0 -
NP -37,157 -43,173 -60,774 -3,286 124.45%
Tax Rate - - - - -
Total Cost 44,070 43,173 60,774 3,286 137.58%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
NP Margin -537.53 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
EPS -0.38 -0.46 -0.68 -0.22 19.98%
EPS Diluted -0.38 -0.46 -0.68 -0.22 19.98%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.